Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
P2Y12 purinoceptor 12 (P2RY12) is a G protein-coupled receptor that primarily functions as a chemoreceptor for adenosine diphosphate (ADP). Highly expressed on platelets and microglia, it mediates ADP-induced platelet aggregation and regulates microglial actions. It is a major therapeutic target for antithrombotic drugs.
Blocks receptor function on platelets, reducing clot formation risk.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P2Y12 purinoceptor 12 (P2RY12).